Publications
- The European Neuroendocrine Tumour Society registry, a tool to assess the prognosis of neuroendocrine neoplasms2022 | First Faculty of Medicine
- Expression of molecules of the Wnt pathway and of E-cadherin in the etiopathogenesis of human thymomas2020 | First Faculty of Medicine, Second Faculty of Medicine
- Neuroendocrine tumors in cases2018 | First Faculty of Medicine
- The ENETS Consensus Quidelines 2016 - somatostatin analogues in the treatment of neuroendocrine tumors2016 | First Faculty of Medicine
- The current view on the treatment of neuroendocrine tumours2015 | First Faculty of Medicine
- An overview of treatment modalities in neuroendocrine neoplasias2013 | First Faculty of Medicine
- Comment to study: A randomized phase |III study of FOLFIRI plus cetuximab or bevacizumab as first-line treatment for wild type (WT) KRAS metastatic colorectal cancer (mCRC) patients: German study AIO KRK-0306(FIRE-3)2013 | First Faculty of Medicine
- Erivedge ® (vismodegib) in advanced basocellular carcer therapy2013 | First Faculty of Medicine
- Colorectal cancer to 1. Surgical Clinic VFN Prague.2012 | First Faculty of Medicine
- Lanreotide autogel/depot in advanced enteropancreatic neuroendocrine tumours: final results of the CLARINET open-label extension study2021 | First Faculty of Medicine
Loading network view...
